(NASDAQ: IRMD) Iradimed's forecast annual revenue growth rate of 6.16% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.41%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,351.34%.
Iradimed's revenue in 2025 is $77,635,163.On average, 3 Wall Street analysts forecast IRMD's revenue for 2025 to be $1,048,331,685, with the lowest IRMD revenue forecast at $1,007,220,638, and the highest IRMD revenue forecast at $1,079,164,970.
In 2026, IRMD is forecast to generate $1,167,696,184 in revenue, with the lowest revenue forecast at $1,121,904,176 and the highest revenue forecast at $1,202,040,189.